glp 1 market forecast GLP-1 Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Weight Loss Drug Market

Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, and Boyd AE, 3rd

Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 Randomized Clinical Trial

Timothy Garvey, MD, professor of medicine and director of the University of Alabama at Birminghams Diabetes Research Center

JCI Insight 5(6):e133429

The transition off GLP-1 medication may actually be easier for you because exercise provides an alternative appetite regulation mechanism and a larger calorie buffer

Unfortunately La Barre's idea was largely forgotten over the next three decades